Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71K Sell
16
-53
-77% -$6.42K ﹤0.01% 809
2026
Q1
$11.3K Buy
69
+1
+1% +$154 ﹤0.01% 608
2025
Q4
$11.8K Buy
+68
New +$12.4K ﹤0.01% 612

Other funds holding INSM

Grove Bank & Trust's INSM Position: Q2 2026 in Review

Grove Bank & Trust reduced its Insmed (INSM) stake by 77% in Q2 2026, selling an estimated $6.42K and leaving 16 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

Grove Bank & Trust first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.8K in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Grove Bank & Trust held 16 shares of Insmed worth $1.71K as of Q2 2026.
  • Grove Bank & Trust sold 53 Insmed shares in Q2 2026, an estimated $6.42K.
  • Insmed made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #809 holding.
  • Grove Bank & Trust first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Grove Bank & Trust's Insmed position peaked at $11.8K in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.